Ceres will publish a market report on current valuations of businesses and product lines that address the following segments with biophotonics technologies:

  • Diagnostics
  • Imaging
  • Life Sciences
  • Medical Devices
  • Therapeutics

Participants in the study will receive:

  • Appraisal or limited appraisal of the business or product line adhering to USPAP (Uniform Standards of Professional Appraisal Practice)
  • Published market report benchmarking to guideline private and public companies

Ceres is offering special pricing to participants that sign-up by August 15.

How to participate, costs, and deadlines>